Time-to-insight refers to the amount of time it takes from data generation to meaningful analysis that can inform decisions during a clinical trial. This metric reflects how quickly sponsors and CROs can detect signals, such as safety events, enrollment slowdowns, or protocol deviations, and respond in real time.